FOXP3 and esophageal squamous cell carcinoma: Konno et al. previously reported that the Foxp3/CD8 ratio was correlated with prognosis of the patients with esophageal squamous cell carcinoma who underwent neoadjuvant chemotherapy (5-fluorouracil+cisplatin) [35].